New Skin-Injection drug joins fight against head & neck cancer
Disease control
Not yet recruiting
This early-stage study is testing if adding an experimental drug called CADI-05 to a standard immunotherapy (pembrolizumab) can better prepare the immune system to fight head and neck cancer before surgery. The main goals are to check the safety of this combination and see if it …
Phase: PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC